These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35773657)

  • 21. Comparison of Bayesian Spatial Ecological Regression Models for Investigating the Incidence of Breast Cancer in Iran, 2005- 2008.
    Khoshkar AH; Koshki TJ; Mahaki B
    Asian Pac J Cancer Prev; 2015; 16(14):5669-73. PubMed ID: 26320433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-benefit analysis of Intensive Care Unit with Activity-Based Costing approach in the era COVID-19 pandemic: A case study from Iran.
    Rahimi H; Goudarzi R; Markazi-Moghaddam N; Nezami-Asl A; Zargar Balaye Jame S
    PLoS One; 2023; 18(5):e0285792. PubMed ID: 37192194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran.
    Ghaffari Darab M; Keshavarz K; Sadeghi E; Shahmohamadi J; Kavosi Z
    BMC Health Serv Res; 2021 Feb; 21(1):132. PubMed ID: 33573650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bayesian adjustment for over-estimation and under-estimation of gastric cancer incidence across Iranian provinces.
    Hajizadeh N; Pourhoseingholi MA; Baghestani AR; Abadi A; Zali MR
    World J Gastrointest Oncol; 2017 Feb; 9(2):87-93. PubMed ID: 28255430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation and predictors of direct hospitalisation expenses and in-hospital mortality for patients who had a stroke in a low-middle income country: evidence from a nationwide cross-sectional study in Iranian hospitals.
    Kazemi Z; Emamgholipour Sefiddashti S; Daroudi R; Ghorbani A; Yunesian M; Hassanvand MS; Shahali Z
    BMJ Open; 2022 Dec; 12(12):e067573. PubMed ID: 36523213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative risk of childhood and adolescence cancer in Iran: spatiotemporal analysis from 1999 to 2016.
    Hashemi H; Mahaki B; Farnoosh R
    BMC Res Notes; 2024 Jan; 17(1):29. PubMed ID: 38238811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with patients' mobility rates within the provinces of Iran.
    Hekmat SN; Haghdoost AA; Zamaninasab Z; Rahimisadegh R; Dehnavieh F; Emadi S
    BMC Health Serv Res; 2022 Dec; 22(1):1556. PubMed ID: 36539751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of stress, anxiety, and depression levels of Pre-Hospital Emergency Medicine personnel in eastern Iran during the Covid-19 pandemic.
    Sabbaghi M; Miri K; Kahi R; Nia MN
    BMC Emerg Med; 2022 Jun; 22(1):97. PubMed ID: 35659184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Joint Spatio-Temporal Shared Component Model with an Application in Iran Cancer Data.
    Mahaki B; Mehrabi Y; Kavousi A; Schmid VJ
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1553-1560. PubMed ID: 29936779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran.
    Sohrabi MR; Amin R; Maher A; Bahadorimonfared A; Janbazi S; Hannani K; Kolahi AA; Zali AR
    BMC Infect Dis; 2021 May; 21(1):474. PubMed ID: 34034649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Intensive Care Unit Admission among Hospitalized COVID-19 Patients in a Large University Hospital in Tehran, Iran.
    Hatami H; Soleimantabar H; Ghasemian M; Delbari N; Aryannezhad S
    J Res Health Sci; 2021 Feb; 21(1):e00510. PubMed ID: 34024768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Assessment of Inequality in the Geographical Distribution of Burn Beds in Iran.
    Geravandi S; Najafi M; Rajaee R; Mahmoudi S; Pakdaman M
    Electron Physician; 2015 Oct; 7(6):1407-11. PubMed ID: 26516451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A spatial-epidemiological dataset of subjects infected by SARS-CoV-2 during the first wave of the pandemic in Mashhad, second-most populous city in Iran.
    MohammadEbrahimi S; Mohammadi A; Bergquist R; Akbarian M; Arian M; Pishgar E; Kiani B
    BMC Res Notes; 2021 Jul; 14(1):292. PubMed ID: 34315517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of ICU-Hospitalized COVID-19 Patients.
    Gholinataj Jelodar M; Rafieian S; Allah Dini A; Khalaj F; Zare S; Dehghanpour H; Mirzaei S
    Can J Infect Dis Med Microbiol; 2023; 2023():3081660. PubMed ID: 37283598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Incidence and Geographical Distribution of Brucellosis in Iran Using Geographic Information System and Prediction of its Incidence in 2021.
    Shirzadi MR; Mohammadi P; Moradi G; Goodarzi E; Khazaei S; Moayed L; Khazaei Z
    J Prev Med Hyg; 2021 Sep; 62(3):E635-E634. PubMed ID: 34909491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.
    Erben Y; Franco-Mesa C; Gloviczki P; Stone W; Quinones-Hinojoas A; Meltzer AJ; Lin M; Greenway MRF; Hamid O; Devcic Z; Toskich B; Ritchie C; Lamb CJ; De Martino RR; Siegel J; Farres H; Hakaim AG; Sanghavi DK; Li Y; Rivera C; Moreno-Franco P; O'Keefe NL; Gopal N; Marquez CP; Huang JF; Kalra M; Shields R; Prudencio M; Gendron T; McBane R; Park M; Hoyne JB; Petrucelli L; O'Horo JC; Meschia JF
    J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1361-1370.e1. PubMed ID: 33836287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Epidemiological Characteristics of Hospitalized COVID-19 Patients in Hormozgan, Iran: A Retrospective, Multicenter Study.
    Hasani Azad M; Khorrami F; Kazemi Jahromi M; Alishan Karami N; Shahi M; Davari Dolatabadi N; Mousavi GS; Sheikhtaheri A
    Arch Iran Med; 2021 May; 24(5):434-444. PubMed ID: 34196210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excess all-cause mortality and COVID-19 reported fatality in Iran (April 2013-September 2021): age and sex disaggregated time series analysis.
    Safavi-Naini SAA; Farsi Y; Alali WQ; Solhpour A; Pourhoseingholi MA
    BMC Res Notes; 2022 Apr; 15(1):130. PubMed ID: 35382865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in health spending after implementation of a health transformation plan in Iran: an interrupted time series analysis.
    Esmaeili R; Rouhani S; Yazdani Charati J; Khandehroo M
    Cost Eff Resour Alloc; 2021 Jun; 19(1):32. PubMed ID: 34082756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Description of Epidemiological Features, Symptoms and Mortality of the Patients with COVID-19 in Some Provinces of Iran.
    Khosravi Shadmani F; Amanollahi A; Zali A; Najafi F; Karami M; Moradi G; Mohammadian-Hafshejani A; Ahmadi A; Sartipi M; Shojaeian M; Noori E; Javaheri M; Bahadorimonfared A; Hashemi-Nazari SS
    Arch Iran Med; 2021 Oct; 24(10):733-740. PubMed ID: 34816694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.